North America Viral Capsid Development Market Size & Outlook
Related Markets
North America viral capsid development market highlights
- The North America viral capsid development market generated a revenue of USD 151.8 million in 2025.
- The market is expected to grow at a CAGR of 10.3% from 2026 to 2033.
- In terms of segment, adeno-associated virus (aav) capsids was the largest revenue generating type in 2025.
- Adeno-Associated Virus (AAV) Capsids is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
| Market revenue in 2025 | USD 151.8 million |
| Market revenue in 2033 | USD 329.0 million |
| Growth rate | 10.3% (CAGR from 2026 to 2033) |
| Largest segment | Adeno-associated virus (aav) capsids |
| Fastest growing segment | Adeno-Associated Virus (AAV) Capsids |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Adeno-Associated Virus (AAV) Capsids, Adenoviral, Lentiviral |
Other key industry trends
- In terms of revenue, North America region accounted for 48.3% of the global viral capsid development market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 130.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viral Capsid Development Market Scope
Viral Capsid Development Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Capsigen | View profile | 11-50 | Vancouver, British Columbia, Canada, North America | https://capsigen.com/ |
| Vigene Biosciences | View profile | 51-100 | Rockville, Maryland, United States, North America | https://www.vigenebio.com |
| Voyager Therapeutics | View profile | 101-250 | Cambridge, Massachusetts, United States, North America | https://www.voyagertherapeutics.com/ |
| AAVnerGene | View profile | 1-10 | Rockville, Maryland, United States, North America | https://aavnergene.com |
| VectorBuilder | View profile | 501-1000 | Chicago, Illinois, United States, North America | https://www.vectorbuilder.com |
| PackGene Biotech | View profile | 251-500 | Houston, Texas, United States, North America | https://www.packgene.com |
| UniQure NV | View profile | 480 | Paasheuvelweg 25, Amsterdam, NH, Netherlands, 1105 BP | https://www.uniqure.com |
| Revvity Inc | View profile | 11500 | 940 Winter Street, Waltham, MA, United States, 02451 | https://www.revvity.com |
| Sartorius AG | View profile | 14338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | https://www.sartorius.com |
North America viral capsid development market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral capsid development market will help companies and investors design strategic landscapes.
Adeno-associated virus (aav) capsids was the largest segment with a revenue share of 44.86% in 2025. Horizon Databook has segmented the North America viral capsid development market based on adeno-associated virus (aav) capsids, adenoviral, lentiviral covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to North America viral capsid development market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America viral capsid development market databook
-
Our clientele includes a mix of viral capsid development market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America viral capsid development market , including forecasts for subscribers. This continent databook contains high-level insights into North America viral capsid development market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
North America viral capsid development market size, by country, 2021-2033 (US$M)
North America Viral Capsid Development Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
